Wells Fargo’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-180
Closed -$4.81K 7296
2024
Q1
$4.81K Buy
180
+167
+1,285% +$2.88K ﹤0.01% 5897
2023
Q4
$177 Buy
13
+1
+8% +$14 ﹤0.01% 6641
2023
Q3
$188 Buy
12
+1
+9% +$19 ﹤0.01% 6602
2023
Q2
$234 Buy
11
+1
+10% +$20 ﹤0.01% 6656
2023
Q1
$185 Hold
10
﹤0.01% 6794
2022
Q4
$173 Hold
10
﹤0.01% 6660
2022
Q3
$0 Hold
10
﹤0.01% 7151
2022
Q2
$1K Buy
+10
New +$522 ﹤0.01% 6560
2022
Q1
Sell
-2
Closed 7590
2021
Q4
$0 Sell
2
-131
-98% -$11K ﹤0.01% 7628
2021
Q3
$11K Sell
133
-1,309
-91% -$115K ﹤0.01% 6176
2021
Q2
$138K Sell
1,442
-221
-13% -$22.6K ﹤0.01% 5167
2021
Q1
$199K Sell
1,663
-2,300
-58% -$333K ﹤0.01% 5152
2020
Q4
$518K Sell
3,963
-970
-20% -$125K ﹤0.01% 4490
2020
Q3
$521K Buy
4,933
+245
+5% +$30.1K ﹤0.01% 4306
2020
Q2
$1.21M Buy
4,688
+3,575
+321% +$1.36M ﹤0.01% 3665
2020
Q1
$495K Buy
1,113
+267
+32% +$143K ﹤0.01% 4045
2019
Q4
$572K Buy
846
+725
+599% +$364K ﹤0.01% 4258
2019
Q3
$45K Buy
121
+119
+5,950% +$38.7K ﹤0.01% 5587
2019
Q2
$0 Buy
+2
New +$416 ﹤0.01% 6538

Other funds holding NXTC

Wells Fargo's NXTC Position: Q2 2024 in Review

Wells Fargo sold out of NextCure (NXTC) in Q2 2024, closing a stake of 180 shares — an estimated $4.81K sold.

Wells Fargo first reported a position in NXTC in Q2 2019 and held it in 19 quarters. The position peaked at $1.21M in Q2 2020. 48 funds tracked by Wall St. Rank hold NXTC as of Q2 2024.

  • Wells Fargo reported no remaining NextCure position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 180 NextCure shares in Q2 2024, an estimated $4.81K.
  • Wells Fargo first reported a position in NextCure in Q2 2019 and held it in 19 quarters.
  • Wells Fargo's NextCure position peaked at $1.21M in Q2 2020.
  • 48 funds tracked by Wall St. Rank held NextCure as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.